Company
Nurix Therapeutics, Inc. (NRIX)
Standardized SEC financial data for Nurix Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001549595 · NASDAQ · Pharmaceutical Preparations.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $17.8M | $29.8M | $38.6M | $77.0M | $54.5M | $84.0M |
| R&D expense | $66.5M | $116.4M | $184.5M | $189.1M | $221.6M | $316.9M |
| SG&A expense | $16.3M | $31.2M |
Standardized from Nurix Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Get NRIX data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/NRIX/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/NRIX/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"